NCT00407017

Brief Summary

The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 4, 2006

Completed
Last Updated

August 21, 2007

Status Verified

August 1, 2007

First QC Date

November 30, 2006

Last Update Submit

August 17, 2007

Conditions

Cataract Surgery

Interventions

GatifloxacinDRUG
Ketorolac LSDRUG
Pred ForteDRUG
MoxifloxacinDRUG
NepafenacDRUG
EconoPred PlusDRUG

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Males or females scheduled to undergo cataract surgery
  • Patients can be receiving monofocal IOLs only
  • Likely to complete all study visits and able to provide informed consent
  • Visual potential of 20/25 or better

You may not qualify if:

  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease
  • Active ocular allergies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Center for Excellence in Eye Care

Miami, Florida, 33176, United States

Location

MeSH Terms

Interventions

Gatifloxacinprednisolone acetateMoxifloxacinnepafenacMethylprednisolone

Intervention Hierarchy (Ancestors)

Fluoroquinolones4-QuinolonesQuinolonesQuinolinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsPrednisolonePregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Officials

  • William Trattler, MD

    The Center For Excellence in Eye Care

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 30, 2006

First Posted

December 4, 2006

Last Updated

August 21, 2007

Record last verified: 2007-08

Locations

US(1)